Personalized Therapy for Generalized Lymphatic Anomaly/Gorham-Stout Disease With a Combination of Sunitinib and Taxol

The recently revised ISSVA classification approved in Melbourne in April 2014 recognizes generalized lymphatic anomaly and lymphatic malformation in Gorham-Stout disease. The 2 entities can overlap in presentation, as both are characterized by destructive lymphatic vessel invasion of the axial skele...

Descripción completa

Detalles Bibliográficos
Autores principales: Rössler, Jochen, Saueressig, Ulrich, Kayser, Gian, von Winterfeld, Moritz, Klement, Gianoula L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Online Articles: Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617281/
https://www.ncbi.nlm.nih.gov/pubmed/26458155
http://dx.doi.org/10.1097/MPH.0000000000000436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617281/
https://www.ncbi.nlm.nih.gov/pubmed/26458155
http://dx.doi.org/10.1097/MPH.0000000000000436

Ejemplares similares